Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,613 | 664 | 99.7% |
| Education | $30.76 | 3 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,157 | 93 | $0 (2024) |
| Novo Nordisk Inc | $1,031 | 64 | $0 (2024) |
| PFIZER INC. | $752.78 | 84 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $687.30 | 38 | $0 (2024) |
| Amgen Inc. | $587.37 | 36 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $521.93 | 31 | $0 (2023) |
| GlaxoSmithKline, LLC. | $464.66 | 38 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $378.98 | 23 | $0 (2023) |
| Allergan, Inc. | $311.80 | 20 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $240.12 | 13 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,389 | 80 | ABBVIE INC. ($275.42) |
| 2023 | $1,440 | 95 | Novo Nordisk Inc ($299.01) |
| 2022 | $1,270 | 82 | ABBVIE INC. ($270.64) |
| 2021 | $1,752 | 116 | AbbVie Inc. ($332.09) |
| 2020 | $955.64 | 61 | Allergan, Inc. ($188.05) |
| 2019 | $720.34 | 51 | SANOFI-AVENTIS U.S. LLC ($121.51) |
| 2018 | $1,059 | 94 | Amgen Inc. ($264.93) |
| 2017 | $1,058 | 88 | Janssen Pharmaceuticals, Inc ($190.50) |
All Payment Transactions
667 individual payment records from CMS Open Payments — Page 1 of 27
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/26/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $23.52 | General |
| Category: RESPIRATORY | ||||||
| 12/20/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $22.44 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 12/18/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $30.30 | General |
| Category: PSYCHIATRY | ||||||
| 12/17/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $16.54 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/17/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $0.87 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/03/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $19.53 | General |
| Category: PSYCHIATRY | ||||||
| 11/26/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.14 | General |
| Category: PAIN | ||||||
| 11/18/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: PSYCHIATRY | ||||||
| 11/08/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $23.25 | General |
| Category: Neuropsychiatry | ||||||
| 11/08/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $3.95 | General |
| Category: PAIN | ||||||
| 11/07/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $26.97 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 11/07/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.27 | General |
| Category: Respiratory | ||||||
| 11/07/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $4.58 | General |
| Category: NEUROSCIENCE | ||||||
| 11/05/2024 | Tactile Systems Technology Inc | Flexitouch Plus (Device), Entre Plus | Food and Beverage | In-kind items and services | $20.60 | General |
| Category: PNEUMATIC COMPRESSOR | ||||||
| 11/04/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $17.41 | General |
| Category: HFCWO | ||||||
| 10/29/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $19.08 | General |
| Category: NEUROSCIENCE | ||||||
| 10/29/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.80 | General |
| Category: Diabetes | ||||||
| 10/28/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $24.97 | General |
| Category: NEPHROLOGY | ||||||
| 10/24/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/18/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $11.65 | General |
| Category: PAIN | ||||||
| 10/10/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $22.73 | General |
| Category: PSYCHIATRY | ||||||
| 10/07/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.30 | General |
| Category: Immunology | ||||||
| 10/04/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $23.87 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 09/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.75 | General |
| Category: NEUROSCIENCE | ||||||
| 09/16/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $26.93 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 1,305 | 1,562 | $184,684 | $81,989 |
| 2022 | 20 | 668 | 987 | $102,436 | $50,485 |
| 2021 | 21 | 951 | 1,305 | $120,717 | $68,727 |
| 2020 | 24 | 1,151 | 3,843 | $187,565 | $100,940 |
All Medicare Procedures & Services
89 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 228 | 307 | $48,737 | $26,292 | 53.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 167 | 167 | $38,358 | $21,171 | 55.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 121 | 136 | $13,968 | $8,023 | 57.4% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 26 | 30 | $10,080 | $6,123 | 60.7% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 124 | 134 | $11,359 | $5,277 | 46.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 22 | 23 | $5,200 | $2,692 | 51.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 22 | 22 | $5,615 | $2,528 | 45.0% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 106 | 114 | $8,410 | $1,831 | 21.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 84 | 184 | $6,440 | $1,830 | 28.4% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 50 | 54 | $6,210 | $1,371 | 22.1% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 15 | 15 | $1,725 | $1,132 | 65.6% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 18 | 18 | $7,200 | $676.62 | 9.4% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 12 | 13 | $738.00 | $450.06 | 61.0% |
| 72100 | X-ray of lower and sacral spine, 2-3 views | Office | 2023 | 15 | 15 | $2,100 | $411.71 | 19.6% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 37 | 43 | $4,032 | $409.36 | 10.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 39 | 41 | $4,399 | $403.49 | 9.2% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 27 | 31 | $2,325 | $320.85 | 13.8% |
| 73502 | X-ray of hip, 2-3 views | Office | 2023 | 12 | 12 | $2,100 | $300.51 | 14.3% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 26 | 29 | $1,392 | $220.69 | 15.9% |
| 69209 | Removal of impacted ear wax by washing | Office | 2023 | 16 | 16 | $855.00 | $193.68 | 22.7% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2023 | 32 | 43 | $1,184 | $161.54 | 13.6% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 32 | 37 | $1,406 | $115.07 | 8.2% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 58 | 66 | $660.00 | $51.53 | 7.8% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2023 | 16 | 12 | $191.25 | $4.66 | 2.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 150 | 150 | $30,750 | $19,687 | 64.0% |
About Dr. Richard Cole, M.D
Dr. Richard Cole, M.D is a Family Medicine healthcare provider based in Stuart, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/07/2005. The National Provider Identifier (NPI) number assigned to this provider is 1972500668.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Richard Cole, M.D has received a total of $9,644 in payments from pharmaceutical and medical device companies, with $1,389 received in 2024. These payments were reported across 667 transactions from 57 companies. The most common payment nature is "Food and Beverage" ($9,613).
As a Medicare-enrolled provider, Cole has provided services to 4,075 Medicare beneficiaries, totaling 7,697 services with total Medicare billing of $302,141. Data is available for 4 years (2020–2023), covering 89 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Stuart, VA
- Active Since 07/07/2005
- Last Updated 07/24/2023
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1972500668
Products in Payments
- VRAYLAR (Drug) $622.86
- XARELTO (Drug) $452.86
- Ozempic (Drug) $385.23
- NURTEC ODT (Drug) $315.37
- Rybelsus (Drug) $267.99
- UBRELVY (Drug) $243.78
- ENTRESTO (Drug) $240.12
- ELIQUIS (Drug) $235.30
- FARXIGA (Drug) $192.77
- BREZTRI (Drug) $189.04
- Prolia (Biological) $184.77
- QULIPTA (Drug) $181.93
- Aimovig (Biological) $173.45
- LINZESS (Drug) $168.29
- REXULTI (Drug) $159.53
- XIFAXAN (Drug) $158.35
- LONHALA MAGNAIR (Drug) $155.76
- Yupelri (Drug) $146.99
- Kerendia (Drug) $146.63
- TOUJEO (Drug) $144.01
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Stuart
Dr. John Minni, D.o, D.O
Family Medicine — Payments: $1.4M
Kevin Fitzgerald, Md, MD
Family Medicine — Payments: $203,602
Dr. Paul Gambino, M.d, M.D
Family Medicine — Payments: $121,348
Richard Dube, Md, MD
Family Medicine — Payments: $17,871
Dr. Richard Weisberg, D.o, D.O
Family Medicine — Payments: $11,274
Suzann Leslie, D.o, D.O
Family Medicine — Payments: $5,835